Alnylam Announces Top-Line Results of Phase IIb Clinical Trial of ALN-RSV01 ... MarketWatch (press release) Lung transplant patients infected with RSV are at risk for both acute rejection and a bronchiolitis obliterans syndrome (BOS). BOS is a progressive inflammatory and fibrotic lesion of the small airways resulting in an irreversible loss of function in ... |
